Upgrade to SI Premium - Free Trial

Apellis Pharmaceuticals (APLS)

41.03 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/31/26 *Est.)

Latest Headlines

Form 15-12G Apellis Pharmaceuticals, May 26, 2026 8:25 AM - SEC Filing Form SCHEDULE 13G/A Apellis Pharmaceuticals, Filed by: Deep Track Capital, LP May 15, 2026 8:38 AM - SEC Filing Form SCHEDULE 13G/A Apellis Pharmaceuticals, Filed by: RTW INVESTMENTS, LP May 15, 2026 8:05 AM - SEC Filing Form 4 Apellis Pharmaceuticals, For: May 14 Filed by: Dunlop A. Sinclair May 14, 2026 7:37 PM - SEC Filing Form 4 Apellis Pharmaceuticals, For: May 14 Filed by: Chopas James George May 14, 2026 7:35 PM - SEC Filing Form 4 Apellis Pharmaceuticals, For: May 14 Filed by: Dolsten Mikael May 14, 2026 7:34 PM - SEC Filing Form 4 Apellis Pharmaceuticals, For: May 14 Filed by: MELTZER LESLIE May 14, 2026 7:33 PM - SEC Filing Form 4 Apellis Pharmaceuticals, For: May 14 Filed by: FONTEYNE PAUL R. May 14, 2026 7:32 PM - SEC Filing Form 4 Apellis Pharmaceuticals, For: May 14 Filed by: Sullivan Timothy Eugene May 14, 2026 7:30 PM - SEC Filing Form 4 Apellis Pharmaceuticals, For: May 14 Filed by: Machiels Alec May 14, 2026 7:29 PM - SEC Filing Form 4 Apellis Pharmaceuticals, For: May 14 Filed by: Deschatelets Pascal May 14, 2026 7:28 PM - SEC Filing Form 4 Apellis Pharmaceuticals, For: May 14 Filed by: Chan Gerald May 14, 2026 7:27 PM - SEC Filing Form 4 Apellis Pharmaceuticals, For: May 14 Filed by: Nicholson Nur May 14, 2026 7:26 PM - SEC Filing Form 4 Apellis Pharmaceuticals, For: May 14 Filed by: Walbert Keli May 14, 2026 7:24 PM - SEC Filing Form 4 Apellis Pharmaceuticals, For: May 14 Filed by: DeLong Mark Jeffrey May 14, 2026 7:23 PM - SEC Filing Form 4 Apellis Pharmaceuticals, For: May 14 Filed by: O'Brien Stephanie Monaghan May 14, 2026 7:22 PM - SEC Filing Form 4 Apellis Pharmaceuticals, For: May 14 Filed by: Boucher Kelley May 14, 2026 7:21 PM - SEC Filing Form 4 Apellis Pharmaceuticals, For: May 14 Filed by: WHEELER CRAIG A May 14, 2026 7:20 PM - SEC Filing Form 4 Apellis Pharmaceuticals, For: May 14 Filed by: Watson David O. May 14, 2026 7:19 PM - SEC Filing Form 4 Apellis Pharmaceuticals, For: May 14 Filed by: Francois Cedric May 14, 2026 7:18 PM - SEC Filing Form 4 Apellis Pharmaceuticals, For: May 14 Filed by: Baumal Caroline May 14, 2026 7:16 PM - SEC Filing Form SCHEDULE 13D/A Apellis Pharmaceuticals, Filed by: BIOGEN INC. May 14, 2026 4:37 PM - SEC Filing Form 25-NSE Apellis Pharmaceuticals, Filed by: Nasdaq Stock Market LLC May 14, 2026 9:52 AM - SEC Filing Form S-8 POS Apellis Pharmaceuticals, May 14, 2026 9:05 AM - SEC Filing Form S-8 POS Apellis Pharmaceuticals, May 14, 2026 9:04 AM - SEC Filing Form S-8 POS Apellis Pharmaceuticals, May 14, 2026 9:03 AM - SEC Filing Form S-8 POS Apellis Pharmaceuticals, May 14, 2026 9:03 AM - SEC Filing Form S-8 POS Apellis Pharmaceuticals, May 14, 2026 9:02 AM - SEC Filing Form S-8 POS Apellis Pharmaceuticals, May 14, 2026 9:02 AM - SEC Filing Form S-8 POS Apellis Pharmaceuticals, May 14, 2026 9:01 AM - SEC Filing Form S-8 POS Apellis Pharmaceuticals, May 14, 2026 9:01 AM - SEC Filing Form S-8 POS Apellis Pharmaceuticals, May 14, 2026 9:00 AM - SEC Filing Form S-8 POS Apellis Pharmaceuticals, May 14, 2026 8:58 AM - SEC Filing Form 8-K Apellis Pharmaceuticals, For: May 14 May 14, 2026 8:45 AM - SEC Filing Form SC TO-T/A Apellis Pharmaceuticals, Filed by: BIOGEN INC. May 14, 2026 7:54 AM - SEC Filing Form SC 14D9/A Apellis Pharmaceuticals, Filed by: Apellis Pharmaceuticals, Inc. May 14, 2026 7:46 AM - SEC Filing Form SCHEDULE 13G Apellis Pharmaceuticals, Filed by: STATE STREET CORP May 12, 2026 9:52 AM - SEC Filing Form SC TO-T/A Apellis Pharmaceuticals, Filed by: BIOGEN INC. May 12, 2026 7:06 AM - SEC Filing Form SC 14D9/A Apellis Pharmaceuticals, Filed by: Apellis Pharmaceuticals, Inc. May 12, 2026 7:01 AM - SEC Filing Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600 May 7, 2026 6:02 PM - PR NewsWire Bright Horizons Family Solutions and Remitly Global to Join S&P SmallCap 600 May 7, 2026 5:18 PM - StreetInsider Form 10-Q Apellis Pharmaceuticals, For: Mar 31 May 7, 2026 6:56 AM - SEC Filing Form SC TO-T/A Apellis Pharmaceuticals, Filed by: BIOGEN INC. May 6, 2026 4:38 PM - SEC Filing Form SC 14D9/A Apellis Pharmaceuticals, Filed by: Apellis Pharmaceuticals, Inc. May 6, 2026 4:31 PM - SEC Filing Form 8-K Apellis Pharmaceuticals, For: Apr 28 May 4, 2026 7:05 AM - SEC Filing Form 4 Apellis Pharmaceuticals, For: Apr 29 Filed by: Baumal Caroline May 1, 2026 4:21 PM - SEC Filing Form 10-K/A Apellis Pharmaceuticals, For: Dec 31 April 28, 2026 7:01 AM - SEC Filing Form 4 Apellis Pharmaceuticals, For: Apr 17 Filed by: Sullivan Timothy Eugene April 20, 2026 4:02 PM - SEC Filing Wells Fargo Downgrades Apellis Pharmaceuticals (APLS) to Equal Weight April 17, 2026 5:14 AM - StreetInsider Mizuho on Apellis Pharmaceuticals (APLS): 'a Great Outcome' April 15, 2026 10:28 AM - StreetInsider Form SC 14D9 Apellis Pharmaceuticals, Filed by: Apellis Pharmaceuticals, Inc. April 14, 2026 7:41 AM - SEC Filing Form SC TO-T Apellis Pharmaceuticals, Filed by: BIOGEN INC. April 14, 2026 7:03 AM - SEC Filing Form 4 Apellis Pharmaceuticals, For: Apr 06 Filed by: O'Brien Stephanie Monaghan April 8, 2026 4:27 PM - SEC Filing Form SC TO-C Apellis Pharmaceuticals, Filed by: BIOGEN INC. April 7, 2026 5:06 PM - SEC Filing Form SCHEDULE 13G/A Apellis Pharmaceuticals, Filed by: WELLINGTON MANAGEMENT GROUP LLP April 7, 2026 12:49 PM - SEC Filing Apellis Pharmaceuticals (APLS) PT Raised to $41 at RBC Capital April 7, 2026 9:05 AM - StreetInsider Shareholder Alert: Ademi LLP investigates whether Apellis Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders April 7, 2026 7:33 AM - StreetInsider Form 3 Apellis Pharmaceuticals, For: Mar 31 Filed by: BIOGEN INC. April 6, 2026 6:12 PM - SEC Filing Form SCHEDULE 13D Apellis Pharmaceuticals, Filed by: BIOGEN INC. April 6, 2026 6:09 PM - SEC Filing Form SC14D9C Apellis Pharmaceuticals, Filed by: Apellis Pharmaceuticals, Inc. April 6, 2026 4:02 PM - SEC Filing Form SC TO-C Apellis Pharmaceuticals, Filed by: BIOGEN INC. April 3, 2026 5:11 PM - SEC Filing Roth/MKM Downgrades Apellis Pharmaceuticals (APLS) to Neutral April 2, 2026 3:04 AM - StreetInsider Roth/MKM Downgrades Apellis Pharmaceuticals (APLS) to Neutral April 2, 2026 3:04 AM - StreetInsider Apellis Pharmaceuticals (APLS) PT Raised to $41 at Mizuho April 1, 2026 9:38 AM - StreetInsider H.C. Wainwright Downgrades Apellis Pharmaceuticals (APLS) to Neutral April 1, 2026 6:06 AM - StreetInsider Raymond James Downgrades Apellis Pharmaceuticals (APLS) to Market Perform April 1, 2026 3:37 AM - StreetInsider Cantor Fitzgerald Downgrades Apellis Pharmaceuticals (APLS) to Neutral April 1, 2026 2:52 AM - StreetInsider JPMorgan Downgrades Apellis Pharmaceuticals (APLS) to Neutral April 1, 2026 2:24 AM - StreetInsider Form SC14D9C Apellis Pharmaceuticals, Filed by: Apellis Pharmaceuticals, Inc. March 31, 2026 5:31 PM - SEC Filing Form 8-K Apellis Pharmaceuticals, For: Mar 30 March 31, 2026 5:09 PM - SEC Filing Form SC TO-C Apellis Pharmaceuticals, Filed by: BIOGEN INC. March 31, 2026 5:08 PM - SEC Filing Form SC TO-C Apellis Pharmaceuticals, Filed by: BIOGEN INC. March 31, 2026 5:02 PM - SEC Filing Citi Downgrades Apellis Pharmaceuticals (APLS) to Neutral March 31, 2026 4:12 PM - StreetInsider Stifel Downgrades Apellis Pharmaceuticals (APLS) to Hold March 31, 2026 4:08 PM - StreetInsider Guggenheim Reiterates Buy Rating on Biogen (BIIB) following Apellis deal March 31, 2026 1:28 PM - StreetInsider Jefferies Downgrades Apellis Pharmaceuticals (APLS) to Hold March 31, 2026 1:12 PM - StreetInsider Apellis Pharmaceuticals (APLS) PT Raised to $41 at Morgan Stanley March 31, 2026 12:26 PM - StreetInsider Apellis Pharmaceuticals (APLS) PT Raised to $41 at Barclays March 31, 2026 12:23 PM - StreetInsider William Blair Downgrades Apellis Pharmaceuticals (APLS) to Market Perform March 31, 2026 11:55 AM - StreetInsider Baird Downgrades Apellis Pharmaceuticals (APLS) to Neutral March 31, 2026 11:51 AM - StreetInsider Needham Downgrades Apellis Pharmaceuticals (APLS) to Hold March 31, 2026 11:45 AM - StreetInsider Apellis Pharmaceuticals (APLS) call put ratio 1.2 calls to 1 put after Biogen (BIIB) acquires March 31, 2026 10:17 AM - StreetInsider Wolfe Research on Apellis Pharmaceuticals (APLS): Biogen deal 'makes sense' at 'good time to sell' March 31, 2026 10:11 AM - StreetInsider Biogen to acquire Apellis for $5.6 billion in cash deal March 31, 2026 6:59 AM - StreetInsider Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology March 31, 2026 6:59 AM - StreetInsider Biogen to acquire Apellis Pharmaceuticals for $5.6 billion or $41/sh plus CVR March 31, 2026 6:45 AM - StreetInsider Form SCHEDULE 13G/A Apellis Pharmaceuticals, Filed by: VANGUARD GROUP INC March 26, 2026 3:49 PM - SEC Filing Apellis Pharmaceuticals (APLS) PT Lowered to $31 at Cantor Fitzgerald March 18, 2026 6:56 AM - StreetInsider Form 4 Apellis Pharmaceuticals, For: Mar 11 Filed by: Francois Cedric March 13, 2026 4:03 PM - SEC Filing Apellis Pharmaceuticals (APLS) PT Raised to $20 at Mizuho March 13, 2026 6:36 AM - StreetInsider Roth/MKM Starts Apellis Pharmaceuticals (APLS) at Buy March 13, 2026 3:27 AM - StreetInsider Roth/MKM Starts Apellis Pharmaceuticals (APLS) at Buy March 13, 2026 3:27 AM - StreetInsider Roth/MKM Starts Apellis Pharmaceuticals (APLS) at Buy March 13, 2026 3:27 AM - StreetInsider Full Article List